¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"oxygen fixation hypothesis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • external pin fixation
    ¹Ù±ùÇɰíÁ¤, ¿ÜºÎÇɰíÁ¤
  • external skeletal fixation
    ¿ÜºÎ°ñ°Ý°íÁ¤, ü¿Ü°ñ°Ý°íÁ¤
  • elastic-band fixation
    ź·ÂºØ´ë°íÁ¤
  • eccentric fixation
    Á߽ɿÜÁÖ½Ã
  • fixation
    1. °íÁ¤ 2. ÁýÂø 3. ÁÖ½Ã
  • fixation axis
    ÁÖ½ÃÃà
  • fixation disparity
    ÁֽýÃÂ÷
  • fixation forceps
    °íÁ¤Áý°Ô
  • fixation hysteria
    °íÂøÈ÷½ºÅ׸®
  • fixation light
    Áֽõî
  • fixation line
    Áֽü±
  • fixation movement
    Áֽÿ
  • fixation nystagmus
    Áֽô«¶³¸², ÁֽþÈÁø
  • following fixation
    ÃßÁ¾ÁÖ½Ã
  • intermaxillary fixation
    À§ÅλçÀ̰íÁ¤(¼ú), »ó¾Ç°£°íÁ¤(¼ú)
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • arterial oxygen tension
    µ¿¸ÆÇ÷»ê¼ÒºÐ¾Ð
  • home oxygen therapy
    °¡Á¤»ê¼Ò¿ä¹ý
  • oxygen tension
    »ê¼ÒºÐ¾Ð, »ê¼ÒÀå·Â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • receptor hypothesis
    ¼ö¿ëü°¡¼³
  • segregation hypothesis
    ºÐ¸®°¡¼³
  • social causation hypothesis
    »çȸ¿øÀΰ¡¼³
  • test hypothesis
    °¡¼³°ËÁ¤
  • two hit hypothesis
    ÀÌŸ°¡¼³
  • unitarian hypothesis
    Ç×üµ¿Àϰ¡¼³
  • alternating fixation
    ±³´ëÁÖ½Ã
  • fixation axis
    ÁÖ½ÃÃà
  • binocular fixation
    µÎ´«ÁÖ½Ã
  • central fixation
    Áß½ÉÁÖ½Ã
  • compensatory fixation reflex
    º¸»óÁֽùݻç
  • complement fixation
    µµ¿òü°áÇÕ
  • complement fixation reaction
    º¸Ã¼°áÇÕ¹ÝÀÀ, µµ¿òü°áÇÕ¹ÝÀÀ
  • complement fixation test
    µµ¿òü°áÇÕ½ÃÇè, º¸Ã¼°áÇÕ½ÃÇè
  • complement fixation unit
    º¸Ã¼°áÇÕ´ÜÀ§
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Hemoglobin-oxygen equilibrium curve
    Çì¸ð±Û·Îºó-»ê¼Ò°î¼±
  • OER [=oxygen enhancement ratio]
    »ê¼Ò°­È­À²
  • PAO2 => alveolar oxygen pressure
    ÆóÆ÷(øËøà)»ê¼Ò¾Ð
  • So2=>oxygen saturation
    »ê¼ÒÆ÷È­µµ
  • active oxygen
    Ȱ¼º»ê¼Ò(üÀàõß«áÈ).
  • altered oxygen affinity
    »ê¼Òģȭ¼º º¯¼º
  • alveolar arterial oxygen gradient
    ÆóÆ÷µ¿¸Æ°£ »ê¼ÒºÐ¾ÐÂ÷.
  • alveolar-arterial oxygen difference
    ÆóÆ÷-µ¿¸Æ »ê¼ÒÂ÷ÀÌ
  • alveolar-arterial oxygen gradient
    ÆóÆ÷µ¿¸Æ°£ »ê¼ÒºÐ¾ÐÂ÷
  • arterial blood oxygen tension
    µ¿¸ÆÇ÷»ê¼Ò Àå·Â.
  • arterial oxygen content
    µ¿¸ÆÇ÷»ê¼ÒÇÔÀ¯·®
  • arterial oxygen saturation
    µ¿¸ÆÇ÷ »ê¼ÒÆ÷È­µµ
  • arterial oxygen tension
    µ¿¸ÆÇ÷»ê¼ÒºÐ¾Ð, µ¿¸ÆÇ÷»ê¼ÒÀå·Â
  • arterial oxygen tension
    µ¿¸ÆÇ÷ »ê¼ÒºÐ¾Ð
  • arterial-venous oxygen content difference
    µ¿¸Æ-Á¤¸Æ»ê¼Ò¿ëÀûÂ÷ÀÌ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • lyon hypothesis
    ¶óÀ̿ °¡¼³, Lyon °¡¼³(¡­Ê£àã)
  • molecular hypothesis
    ºÐÀÚ°¡¼³.
  • null hypothesis ÀÇ»ç
    ±Í¹«°¡¼³(~˧Ëç).
  • receptor hypothesis
    ¼ö¿ëü°¡¼³
  • segregation hypothesis
    ºÐ¸®°¡¼³
  • social causation hypothesis
    »çȸ¿øÀΰ¡¼³
  • starling hypothesis
    ½ºÅ»¸µÀÇ °¡¼³(¡­Ê£àã)
  • two hit hypothesis
    ÀÌŸ°¡¼³
  • unitarian hypothesis
    Ç×üµ¿Àϼ³
  • alternating fixation
    ±³´ëÁÖ½Ã
  • anomalous fixation
    ÀÌ»óÁÖ½Ã
  • autoimmune complement fixation =AICF
    ÀÚ±â¸é¿ª¼º º¸Ã¼°áÇÕ¹ÝÀÀ(¡­ÜÍô÷Ì¿ùêÚãëë).
  • autoimmune complement fixation =AICF
    ÀÚ°¡¸é¿ª¼º º¸Ã¼°áÇÕ¹ÝÀÀ(¡­ÜÍô÷Ì¿ùêÚãëë).
  • autoimmune complement fixation =AICF
    ÀÚ±â¸é¿ª¼º º¸Ã¼°áÇÕ¹ÝÀÀ(?ËÓ̧˭̰ËÑËô).
  • bifoveal fixation
    ¾ç¾ÈÁ߽ɿÍÁÖ½Ã
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ammonia fixation
    ¾Ï¸ð´Ï¾Æ°íÁ¤(ͳïÒ)
  • antibody fixation
    Ç×ü °íÁ¤(ù÷ô÷ͳïÒ)
  • artificial nitrogen fixation
    Àΰø Áú¼Ò°íÁ¤ (ìÑÍïòòáÈͳïÒ)
  • autoimmune complement fixation
    ÀÚ°¡¸é¿ª (í»Ê«Øóæ¹) º¸Ã¼°íÁ¤ (ÜÍô÷ͳïÒ)
  • biological nitrogen fixation
    »ý¹°ÇÐÀû Áú¼Ò°íÁ¤(ßæÚªùÊîÜòòáÈͳïÒ)
  • carbon dioxide fixation
    ÀÌ»êȭź¼Ò °íÁ¤(ì£ß«ûù÷©áÈͳïÒ)
  • carbon fixation
    ź¼Ò°íÁ¤(÷©áÈͳïÒ)
  • carbon-fixation cycle
    ź¼Ò°íÁ¤ ȸ·Î(÷©áÈͳïÒüÞÖØ)
  • complement fixation
    º¸Ã¼°íÁ¤(ÜÍô÷ͳïÒ)
  • complement fixation inhibition test
    º¸Ã¼°íÁ¤ ÀúÇØ½ÃÇè(ÜÍô÷ͳïÒîÁúªãËúÐ)
  • complement fixation test
    º¸Ã¼°íÁ¤½ÃÇè(ÜÍô÷ͳïÒãËúÐ)
  • double carbon dioxide fixation
    ÀÌÁß ÀÌ»êȭź¼Ò °íÁ¤(ì£ñìì£ß«ûù÷©áÈͳïÒ)
  • fixation
    °íÁ¤(ͳïÒ)
  • indirect complement fixation test
    °£Á¢º¸Ã¼°íÁ¤½ÃÇè(ÊàïÈÜÍô÷ͳïÒãËúÐ)
  • nitrogen fixation
    Áú¼Ò°íÁ¤(òòáÈͳïÒ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
HO hand orthosis; heterotopic ossification; high oxygen; hip orthosis; history of; Holt-Oram [syndrome]...
O2 both eyes; diatomic oxygen; molecular oxygen
PaO2 partial oxygen tension in arterial blood; partial pressure of oxygen in arterial blood
QO2 oxygen quotient; oxygen utilization
CF test Complement Fixation test; º¸Ã¼°áÇÕ¹ý
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CFT Complement Fixation Test
FD Fixation disparity
IMF Intermaxillary fixation
Nif Nitrogen fixation
ORIF Open reduction and internal fixation
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • fixation nystagmus
    °í½Ã ¾ÈÁø
  • intermaxillary fixation
    ¾Ç°£ °íÁ¤
  • internal fixation
    ³»ºÎ °íÁ¤
  • interosseous fixation
    °ñ°£ °íÁ¤
  • macular fixation
    Ȳ¹Ý ÁÖ½Ã
  • maxillomandibular fixation
    »óÇϾǰñ °íÁ¤¼ú
  • parafoveal fixation
    Áß½É¿Í ºÎ±Ù ÁÖ½Ã
  • paramacular fixation
    Ȳ¹Ý ºÎ±Ù ÁÖ½Ã
  • rigid internal fixation
    °ß°í³» °íÁ¤
  • sulcus fixation
    ¸ð¾çü °í¶û °íÁ¤
  • suspension wire fixation
    Çö¼ö °­¼± °íÁ¤
  • temporary fixation
    Àӽà °íÁ¤
  • treponema pallidum complement fixation test
    Æ®·¹Æ÷³×¸¶ º¸Ã¼ °áÇÕ ½ÃÇè
  • alveolar arterial oxygen gradient
    ÆóÆ÷µ¿¸Æ°£ »ê¼Ò ºÐ¾ÐÂ÷
  • alveolar-arterial oxygen difference
    ÆóÆ÷-µ¿¸Æ »ê¼Ò Â÷ÀÌ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
sliding filament hypothesis The theory that the contracting muscle shortens because two sets of filaments slide past each other.
(05 Mar 2000)
Starling's hypothesis The principle that net filtration through capillary membranes is proportional to the transmembrane hydrostatic pressure difference minus the transmembrane oncotic pressure difference; although well established, it is called Starling's hypothesis to distinguish it from Starling's law of the heart.
(05 Mar 2000)
Neyman-Pearson statistical hypothesis A formal conjecture about the numerical value of a parameter to be tested exclusively in the light of an immediate set of data without attention to prior knowledge or convictions and ignoring other sets of evidence treated in a similar fashion. The answer is a statement not about whether the hypothesis is true but whether it is an acceptable explanation of the data or should be rejected in favour of another hypothesis.
(05 Mar 2000)
null hypothesis The assumption that any observed difference between two samples of a statistical population is purely accidental and not due to systematic causes.
(05 Dec 1998)
dual recognition hypothesis An outmoded hypothesis that is known to be incorrect now that the structure of the T-cell receptor is known. The proposal was that viral (and some chemical) antigens were recognised in association with histocompatibility antigens by separate receptors on the T-cell. The generation of cytotoxic T-cells was by association with Class I MHC antigens, of T helper cells by association with Class II MHC antigens.
See: altered self hypothesis.
(18 Nov 1997)
insular hypothesis An obsolete theory of the origin of diabetes mellitus from destruction or loss of function of the islets of Langerhans in the pancreas.
(05 Mar 2000)
endosymbiont hypothesis The hypothesis that semi autonomous organelles such as mitochondria and chloroplasts were originally endosymbiotic bacteria or cyanobacteria. The arguments are convincing and although the hypothesis cannot be proven it is widely accepted.
(18 Nov 1997)
uniform rate hypothesis <biology> This states that any two evolving organismal lineages diverge from a common ancestor at a constant rate with respect to each other.
(09 Oct 1997)
unineme hypothesis <cell biology, molecular biology> This states that that a chromatid has only one DNA duplex, which goes from one end of the chromatid to the other.
(09 Oct 1997)
zwitter hypothesis That an amphoteric molecule (e.g., an amino acid) has, at its isoelectric point, equal numbers of positive and negative charges, thus becoming a zwitterion.
(05 Mar 2000)
frustration-aggression hypothesis The theory that frustration may lead to aggression, but that aggression is always the result of some form of frustration.
(05 Mar 2000)
Lyon hypothesis <genetics> Hypothesis, first advanced by Lyon, concerning the random inactivation of one of the two X chromosomes of the cells of female mammals.
In consequence females are chimaeric for the products of the X chromosomes, a situation that has been exploited in female Negroes (who are heterotypic for isozymes of glucose 6 phosphate dehydrogenase) as a means to confirm the monoclonal origin of papillomas and of atherosclerotic plaques.
(20 Mar 1998)
alactic oxygen debt That part of the oxygen debt that is not lactacid oxygen debt; during recovery, stores of ATP and creatine phosphate must be replenished by oxidative metabolism, and a small amount of oxygen is also needed to restore the normal oxyhemoglobin levels throughout the circulating blood.
(05 Mar 2000)
alveolar-arterial oxygen difference The difference or gradient between the partial pressure of oxygen in the alveolar spaces and the arterial blood: P(A-a)02. Normally in young adults this value is less than 20 mm Hg.
See: alveolar gas equation.
(05 Mar 2000)
arteriovenous oxygen difference <physiology> The difference in the oxygen content (in ml per 100 ml blood) between arterial and venous blood.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á